Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.

By Christy Santhosh and Kamal Choudhury (Reuters) -Drug distributor Cardinal Health said on Thursday it may need to increase prices of some of its products if the proposed tariffs on Mexico go into ...

In its motion to dismiss, J&J asserted that the plaintiff did “not allege a concrete harm or injury-in-fact” — a claim with ...

In our new study, people told us they’d been fined for leaving home to access drug treatment programs – and still couldn’t ...

Lonza Group has been a dominant player in the contract development and manufacturing space for decades. We think the outlook for Lonza looks bright, especially as drug manufacturing becomes more ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Legislators and medical policy advocates revealed the proposal at a press conference Wednesday at the capitol in Springfield.

SaveHealth explores the potential prescription cost savings that can be achieved by leveraging cash prices and discount cards ...

Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...

The recent Senate confirmation hearings for Robert F. Kennedy Jr. presented a striking scene that would confuse a time ...

During the year ending last August, according to preliminary estimates from the Centers for Disease Control and Prevention ...

To save taxpayer money and rebuild the economy, Congress should repeal Biden's poorly named Inflation Reduction Act ...